T1	B-Protein	0	7	Protein	Protein	B-NP	NN	B-protein	3	NMOD	B-protein
T1	I-Protein	8	14	kinase	kinase	I-NP	NN	I-protein	3	NMOD	I-protein
T1	I-Protein	15	16	C	C	I-NP	NN	I-protein	5	NMOD	I-protein
T1	I-Protein	16	17	-	-	B-NP	HYPH	O	5	NMOD	O
T1	I-Protein	17	21	zeta	zeta	I-NP	NN	O	6	SUB	O
O	O	22	30	mediates	mediate	B-VP	VBZ	O	0	ROOT	O
T10	B-Entity	31	33	NF	NF	B-NP	NN	B-protein	11	NMOD	B-protein
T10	I-Entity	33	34	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T10	I-Entity	34	39	kappa	kappa	I-NP	NN	I-protein	11	NMOD	I-protein
T10	I-Entity	40	41	B	B	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	42	52	activation	activation	I-NP	NN	O	6	OBJ	O
O	O	53	55	in	in	B-PP	IN	O	6	VMOD	O
O	O	56	61	human	human	B-NP	JJ	O	15	NMOD	O
O	O	62	78	immunodeficiency	immunodeficiency	I-NP	NN	O	15	NMOD	O
O	O	79	84	virus	virus	I-NP	NN	O	18	NMOD	O
O	O	84	85	-	-	B-NP	HYPH	O	18	P	O
O	O	85	93	infected	infect	I-NP	VBN	O	18	NMOD	O
O	O	94	103	monocytes	monocyte	I-NP	NNS	B-cell_type	12	PMOD	B-cell_type
O	O	103	104	.	.	O	.	O	6	P	O

O	O	106	109	The	The	B-NP	DT	O	3	NMOD	O
O	O	110	119	molecular	molecular	I-NP	JJ	O	3	NMOD	O
O	O	120	130	mechanisms	mechanism	I-NP	NNS	O	21	SUB	O
O	O	131	141	regulating	regulate	B-VP	VBG	O	3	NMOD	O
O	O	142	147	human	human	B-NP	JJ	O	7	NMOD	O
O	O	148	164	immunodeficiency	immunodeficiency	I-NP	NN	O	7	NMOD	O
O	O	165	170	virus	virus	I-NP	NN	O	11	NMOD	O
O	O	171	172	(	(	O	(	O	10	DEP	O
O	O	172	175	HIV	HIV	B-NP	NN	O	10	DEP	O
O	O	175	176	)	)	O	)	O	7	NMOD	O
O	O	177	188	persistence	persistence	B-NP	NN	O	4	OBJ	O
O	O	189	191	in	in	B-PP	IN	O	11	NMOD	O
O	O	192	193	a	a	B-NP	DT	O	16	NMOD	O
O	O	194	199	major	major	I-NP	JJ	O	16	NMOD	O
O	O	200	204	cell	cell	I-NP	NN	O	16	NMOD	O
O	O	205	214	reservoir	reservoir	I-NP	NN	O	12	PMOD	O
O	O	215	219	such	such	B-PP	JJ	O	18	PMOD	O
O	O	220	222	as	as	I-PP	IN	O	16	NMOD	O
O	O	223	226	the	the	B-NP	DT	O	20	NMOD	O
O	O	227	237	macrophage	macrophage	I-NP	NN	B-cell_type	18	PMOD	B-cell_type
O	O	238	244	remain	remain	B-VP	VBP	O	0	ROOT	O
O	O	245	252	unknown	unknown	B-ADJP	JJ	O	21	PRD	O
O	O	252	253	.	.	O	.	O	21	P	O

T11	B-Entity	254	256	NF	NF	B-NP	NN	B-protein	4	NMOD	B-protein
T11	I-Entity	256	257	-	-	I-NP	HYPH	I-protein	4	NMOD	I-protein
T11	I-Entity	257	262	kappa	kappa	I-NP	NN	I-protein	4	NMOD	I-protein
T11	I-Entity	263	264	B	B	I-NP	NN	I-protein	5	SUB	I-protein
O	O	265	267	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	268	269	a	a	B-NP	DT	O	8	NMOD	O
O	O	270	283	transcription	transcription	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	284	290	factor	factor	I-NP	NN	I-protein	5	PRD	I-protein
O	O	291	299	involved	involve	B-VP	VBN	O	8	NMOD	O
O	O	300	302	in	in	B-PP	IN	O	9	VMOD	O
O	O	303	306	the	the	B-NP	DT	O	12	NMOD	O
O	O	307	317	regulation	regulation	I-NP	NN	O	10	PMOD	O
O	O	318	320	of	of	B-PP	IN	O	12	NMOD	O
O	O	321	324	the	the	B-NP	DT	O	18	NMOD	O
T12	B-Entity	325	328	HIV	HIV	I-NP	NN	B-DNA	18	NMOD	B-DNA
T12	I-Entity	329	333	long	long	I-NP	JJ	I-DNA	18	NMOD	I-DNA
T12	I-Entity	334	342	terminal	terminal	I-NP	JJ	I-DNA	18	NMOD	I-DNA
T12	I-Entity	343	349	repeat	repeat	I-NP	NN	I-DNA	13	PMOD	I-DNA
O	O	350	353	and	and	O	CC	O	5	VMOD	O
O	O	354	356	is	be	B-VP	VBZ	O	5	VMOD	O
O	O	357	368	selectively	selectively	I-VP	RB	O	22	VMOD	O
O	O	369	378	activated	activate	I-VP	VBN	O	20	VC	O
O	O	379	388	following	follow	B-PP	VBG	O	22	VMOD	O
O	O	389	392	HIV	HIV	B-NP	NN	O	25	NMOD	O
O	O	393	402	infection	infection	I-NP	NN	O	23	PMOD	O
O	O	403	405	of	of	B-PP	IN	O	25	NMOD	O
O	O	406	411	human	human	B-NP	JJ	B-cell_type	28	NMOD	B-cell_type
O	O	412	423	macrophages	macrophage	I-NP	NNS	I-cell_type	26	PMOD	I-cell_type
O	O	423	424	.	.	O	.	O	5	P	O

O	O	425	433	Although	Although	B-SBAR	IN	O	26	VMOD	O
O	O	434	440	little	little	B-NP	JJ	O	3	NMOD	O
O	O	441	452	information	information	I-NP	NN	O	20	SUB	O
O	O	453	455	as	as	B-PP	IN	O	3	NMOD	O
O	O	456	458	to	to	B-PP	TO	O	10	VMOD	O
O	O	459	463	what	what	B-NP	WP	O	10	VMOD	O
O	O	464	470	signal	signal	B-NP	NN	O	6	NMOD	O
O	O	471	483	transduction	transduction	I-NP	NN	O	6	NMOD	O
O	O	484	492	pathways	pathway	I-NP	NNS	O	6	NMOD	O
O	O	493	500	mediate	mediate	B-VP	VBP	O	4	SBAR	O
T13	B-Entity	501	503	NF	NF	B-NP	NN	B-protein	15	NMOD	B-protein
T13	I-Entity	503	504	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T13	I-Entity	504	509	kappa	kappa	I-NP	NN	I-protein	15	NMOD	I-protein
T13	I-Entity	510	511	B	B	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	512	522	activation	activation	I-NP	NN	O	10	OBJ	O
O	O	523	525	in	in	B-PP	IN	O	15	NMOD	O
O	O	526	535	monocytes	monocyte	B-NP	NNS	B-cell_type	19	NMOD	B-cell_type
O	O	535	536	-	-	O	HYPH	O	19	NMOD	O
O	O	536	547	macrophages	macrophage	B-NP	NNS	B-cell_type	16	PMOD	B-cell_type
O	O	548	550	is	be	B-VP	VBZ	O	1	SBAR	O
O	O	551	560	available	available	B-ADJP	JJ	O	20	PRD	O
O	O	560	561	,	,	O	,	O	26	P	O
O	O	562	565	our	our	B-NP	PRP$	O	25	NMOD	O
O	O	566	574	previous	previous	I-NP	JJ	O	25	NMOD	O
O	O	575	579	work	work	I-NP	NN	O	26	SUB	O
O	O	580	589	indicated	indicate	B-VP	VBD	O	0	ROOT	O
O	O	590	594	that	that	B-SBAR	IN	O	26	VMOD	O
O	O	595	604	classical	classical	B-NP	JJ	O	36	SUB	O
O	O	605	612	protein	protein	I-NP	NN	B-protein	31	NMOD	B-protein
O	O	613	619	kinase	kinase	I-NP	NN	I-protein	31	NMOD	I-protein
O	O	620	621	C	C	I-NP	NN	I-protein	35	NMOD	I-protein
O	O	622	623	(	(	O	(	O	34	DEP	O
O	O	623	626	PKC	PKC	B-NP	NN	B-protein	34	DEP	B-protein
O	O	626	627	)	)	O	)	O	31	NMOD	O
O	O	628	638	isoenzymes	isoenzyme	B-NP	NNS	O	28	NMOD	O
O	O	639	643	were	be	B-VP	VBD	O	27	SBAR	O
O	O	644	647	not	not	I-VP	RB	O	36	VMOD	O
O	O	648	656	involved	involve	I-VP	VBN	O	36	VC	O
O	O	657	659	in	in	B-PP	IN	O	38	VMOD	O
O	O	660	663	the	the	B-NP	DT	O	48	NMOD	O
O	O	664	667	HIV	HIV	I-NP	NN	O	48	NMOD	O
O	O	667	668	-	-	B-VP	HYPH	O	48	P	O
O	O	668	676	mediated	mediate	B-NP	VBN	O	48	NMOD	O
T14	B-Entity	677	679	NF	NF	I-NP	NN	B-protein	48	NMOD	B-protein
T14	I-Entity	679	680	-	-	B-NP	HYPH	I-protein	48	NMOD	I-protein
T14	I-Entity	680	685	kappa	kappa	I-NP	NN	I-protein	48	NMOD	I-protein
T14	I-Entity	686	687	B	B	I-NP	NN	I-protein	48	NMOD	I-protein
O	O	688	698	activation	activation	I-NP	NN	O	39	PMOD	O
O	O	698	699	.	.	O	.	O	26	P	O

O	O	700	702	In	In	B-PP	IN	O	6	VMOD	O
O	O	703	707	this	this	B-NP	DT	O	3	NMOD	O
O	O	708	713	study	study	I-NP	NN	O	1	PMOD	O
O	O	713	714	,	,	O	,	O	6	P	O
O	O	715	717	we	we	B-NP	PRP	O	6	SUB	O
O	O	718	722	have	have	B-VP	VBP	O	0	ROOT	O
O	O	723	730	focused	focus	I-VP	VBN	O	6	VC	O
O	O	731	733	on	on	B-PP	IN	O	7	VMOD	O
O	O	734	742	atypical	atypical	B-NP	JJ	O	8	PMOD	O
O	O	743	746	PKC	PKC	I-NP	NN	B-protein	11	NMOD	B-protein
O	O	747	757	isoenzymes	isoenzyme	I-NP	NNS	I-protein	9	NMOD	I-protein
O	O	757	758	.	.	O	.	O	6	P	O

T2	B-Protein	759	762	PKC	PKC	B-NP	NN	B-protein	3	NMOD	B-protein
T2	I-Protein	762	763	-	-	I-NP	HYPH	O	3	NMOD	O
T2	I-Protein	763	767	zeta	zeta	I-NP	NN	O	4	SUB	O
O	O	768	775	belongs	belong	B-VP	VBZ	O	0	ROOT	O
O	O	776	778	to	to	B-PP	TO	O	4	VMOD	O
O	O	779	783	this	this	B-NP	DT	O	7	NMOD	O
O	O	784	790	family	family	I-NP	NN	O	5	PMOD	O
O	O	791	794	and	and	O	CC	O	4	VMOD	O
O	O	795	797	is	be	B-VP	VBZ	O	4	VMOD	O
O	O	798	803	known	know	I-VP	VBN	O	9	VC	O
O	O	804	806	to	to	I-VP	TO	O	12	VMOD	O
O	O	807	809	be	be	I-VP	VB	O	10	VMOD	O
O	O	810	812	an	an	B-NP	DT	O	15	NMOD	O
O	O	813	822	important	important	I-NP	JJ	O	15	NMOD	O
O	O	823	827	step	step	I-NP	NN	O	12	PRD	O
O	O	828	830	in	in	B-PP	IN	O	15	NMOD	O
T15	B-Entity	831	833	NF	NF	B-NP	NN	B-protein	21	NMOD	B-protein
T15	I-Entity	833	834	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T15	I-Entity	834	839	kappa	kappa	I-NP	NN	I-protein	21	NMOD	I-protein
T15	I-Entity	840	841	B	B	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	842	852	activation	activation	I-NP	NN	O	16	PMOD	O
O	O	853	855	in	in	B-PP	IN	O	21	NMOD	O
O	O	856	861	other	other	B-NP	JJ	O	25	NMOD	O
O	O	862	866	cell	cell	I-NP	NN	O	25	NMOD	O
O	O	867	874	systems	system	I-NP	NNS	O	22	PMOD	O
O	O	874	875	.	.	O	.	O	4	P	O

O	O	876	890	Immunoblotting	Immunoblotting	B-NP	NN	O	2	NMOD	O
O	O	891	902	experiments	experiment	I-NP	NNS	O	6	SUB	O
O	O	903	907	with	with	B-PP	IN	O	2	NMOD	O
O	O	908	912	U937	U937	B-NP	NN	B-cell_line	5	NMOD	B-cell_line
O	O	913	918	cells	cell	I-NP	NNS	I-cell_line	3	PMOD	I-cell_line
O	O	919	930	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	931	935	that	that	B-SBAR	IN	O	6	VMOD	O
T3	B-Protein	936	939	PKC	PKC	B-NP	NN	B-protein	10	NMOD	B-protein
T3	I-Protein	939	940	-	-	B-NP	HYPH	O	10	NMOD	O
T3	I-Protein	940	944	zeta	zeta	I-NP	NN	O	11	SUB	O
O	O	945	947	is	be	B-VP	VBZ	O	7	SBAR	O
O	O	948	955	present	present	B-ADJP	JJ	O	11	PRD	O
O	O	956	958	in	in	B-PP	IN	O	12	AMOD	O
O	O	959	964	these	these	B-NP	DT	O	15	NMOD	O
O	O	965	970	cells	cell	I-NP	NNS	O	13	PMOD	O
O	O	970	971	,	,	O	,	O	7	P	O
O	O	972	975	and	and	O	CC	O	7	DEP	O
O	O	976	979	its	its	B-NP	PRP$	O	19	NMOD	O
O	O	980	990	expression	expression	I-NP	NN	O	20	SUB	O
O	O	991	994	can	can	B-VP	MD	O	7	SBAR	O
O	O	995	997	be	be	I-VP	VB	O	20	VC	O
O	O	998	1011	downmodulated	downmodulate	I-VP	VBN	O	21	VC	O
O	O	1012	1014	by	by	B-PP	IN	O	22	VMOD	O
T16	B-Entity	1015	1024	antisense	antisense	B-NP	JJ	O	25	NMOD	O
T16	I-Entity	1025	1041	oligonucleotides	oligonucleotide	I-NP	NNS	O	23	PMOD	O
O	O	1042	1043	(	(	O	(	O	28	DEP	O
T17	B-Entity	1043	1045	AO	AO	B-NP	NN	O	28	DEP	O
O	O	1045	1046	)	)	O	)	O	25	NMOD	O
O	O	1046	1047	.	.	O	.	O	6	P	O

O	O	1048	1051	The	The	B-NP	DT	O	2	NMOD	O
O	O	1052	1055	HIV	HIV	I-NP	NN	O	9	NMOD	O
O	O	1055	1056	-	-	B-VP	HYPH	O	2	P	O
O	O	1056	1064	mediated	mediate	B-NP	VBN	O	9	NMOD	O
T18	B-Entity	1065	1067	NF	NF	I-NP	NN	B-protein	9	NMOD	B-protein
T18	I-Entity	1067	1068	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T18	I-Entity	1068	1073	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T18	I-Entity	1074	1075	B	B	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	1076	1086	activation	activation	I-NP	NN	O	10	SUB	O
O	O	1087	1089	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1090	1101	selectively	selectively	I-VP	RB	O	10	VMOD	O
O	O	1102	1109	reduced	reduce	I-VP	VBN	O	10	VC	O
O	O	1110	1112	by	by	B-PP	IN	O	12	VMOD	O
T19,T20	B-Entity,B-Entity	1113	1115	AO	AO	B-NP	NN	O	13	PMOD	O
T19	I-Entity	1116	1118	to	to	B-PP	TO	O	12	VMOD	O
T4,T19	B-Protein,I-Entity	1119	1122	PKC	PKC	B-NP	NN	B-protein	18	NMOD	B-protein
T4,T19	I-Protein,I-Entity	1122	1123	-	-	B-NP	HYPH	O	18	NMOD	O
T4,T19	I-Protein,I-Entity	1123	1127	zeta	zeta	I-NP	NN	O	15	PMOD	O
T19	I-Entity	1127	1128	.	.	O	.	O	10	P	O

O	O	1129	1131	In	In	B-PP	IN	O	30	VMOD	O
O	O	1132	1140	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	1140	1141	,	,	O	,	O	30	P	O
O	O	1142	1156	cotransfection	cotransfection	B-NP	NN	O	30	SUB	O
O	O	1157	1159	of	of	B-PP	IN	O	4	NMOD	O
O	O	1160	1161	a	a	B-NP	DT	O	9	NMOD	O
O	O	1162	1170	negative	negative	I-NP	JJ	O	9	NMOD	O
O	O	1171	1179	dominant	dominant	I-NP	JJ	O	9	NMOD	O
O	O	1180	1188	molecule	molecule	I-NP	NN	O	5	PMOD	O
O	O	1189	1191	of	of	B-PP	IN	O	9	NMOD	O
T5	B-Protein	1192	1195	PKC	PKC	B-NP	NN	B-protein	10	PMOD	B-protein
T5	I-Protein	1195	1196	-	-	O	HYPH	O	13	P	O
T5	I-Protein	1196	1200	zeta	zeta	B-NP	SYM	O	9	NMOD	O
O	O	1201	1202	(	(	O	(	O	19	DEP	O
T6	B-Protein	1202	1205	PKC	PKC	B-NP	NN	B-protein	18	NMOD	B-protein
T6	I-Protein	1205	1206	-	-	O	HYPH	O	18	P	O
T6	I-Protein	1206	1210	zeta	zeta	B-NP	SYM	O	18	NMOD	O
O	O	1211	1214	mut	mut	I-NP	NN	O	19	DEP	O
O	O	1214	1215	)	)	O	)	O	13	AMOD	O
O	O	1216	1220	with	with	B-PP	IN	O	4	NMOD	O
T21	B-Entity	1221	1223	NF	NF	B-NP	NN	B-protein	24	NMOD	B-protein
T21	I-Entity	1223	1224	-	-	O	HYPH	I-protein	24	NMOD	I-protein
T21	I-Entity	1224	1229	kappa	kappa	B-NP	NN	I-protein	24	NMOD	I-protein
T21	I-Entity	1230	1231	B	B	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	1231	1232	-	-	B-NP	HYPH	O	28	P	O
O	O	1232	1241	dependent	dependent	I-NP	JJ	O	28	NMOD	O
O	O	1242	1250	reporter	reporter	I-NP	NN	B-DNA	28	NMOD	B-DNA
O	O	1251	1256	genes	gene	I-NP	NNS	I-DNA	20	PMOD	I-DNA
O	O	1257	1268	selectively	selectively	B-ADVP	RB	O	30	VMOD	O
O	O	1269	1277	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
O	O	1278	1281	the	the	B-NP	DT	O	44	NMOD	O
O	O	1282	1285	HIV	HIV	I-NP	NN	O	44	NMOD	O
O	O	1285	1286	-	-	B-VP	HYPH	O	44	P	O
O	O	1287	1290	but	but	B-NP	CC	O	44	NMOD	O
O	O	1291	1294	not	not	I-NP	RB	O	34	DEP	O
O	O	1295	1302	phorbol	phorbol	B-NP	NN	O	38	NMOD	O
O	O	1303	1312	myristate	myristate	I-NP	NN	O	38	NMOD	O
O	O	1313	1320	acetate	acetate	I-NP	NN	O	44	NMOD	O
O	O	1320	1321	-	-	B-VP	HYPH	O	38	P	O
O	O	1322	1324	or	or	O	CC	O	44	NMOD	O
O	O	1325	1343	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	44	NMOD	O
O	O	1343	1344	-	-	O	HYPH	O	41	P	O
O	O	1344	1352	mediated	mediate	B-NP	VBN	O	44	NMOD	O
O	O	1353	1363	activation	activation	I-NP	NN	O	30	OBJ	O
O	O	1364	1366	of	of	B-PP	IN	O	44	NMOD	O
T22	B-Entity	1367	1369	NF	NF	B-NP	NN	B-protein	49	NMOD	B-protein
T22	I-Entity	1369	1370	-	-	B-NP	HYPH	I-protein	49	NMOD	I-protein
T22	I-Entity	1370	1375	kappa	kappa	I-NP	NN	I-protein	49	NMOD	I-protein
T22	I-Entity	1376	1377	B	B	I-NP	NN	I-protein	45	PMOD	I-protein
O	O	1377	1378	.	.	O	.	O	30	P	O

O	O	1379	1383	That	That	B-NP	DT	O	4	NMOD	O
T7	B-Protein	1384	1387	PKC	PKC	I-NP	NN	B-protein	4	NMOD	B-protein
T7	I-Protein	1387	1388	-	-	B-NP	HYPH	O	4	NMOD	O
T7	I-Protein	1388	1392	zeta	zeta	I-NP	NN	O	5	SUB	O
O	O	1393	1395	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1396	1404	specific	specific	B-ADJP	JJ	O	5	PRD	O
O	O	1405	1407	in	in	B-PP	IN	O	6	AMOD	O
O	O	1408	1418	regulating	regulate	B-VP	VBG	O	7	PMOD	O
T23	B-Entity	1419	1421	NF	NF	B-NP	NN	B-protein	12	NMOD	B-protein
T23	I-Entity	1421	1422	-	-	B-NP	HYPH	I-protein	12	NMOD	I-protein
T23	I-Entity	1422	1427	kappa	kappa	I-NP	NN	I-protein	12	NMOD	I-protein
T23	I-Entity	1428	1429	B	B	I-NP	NN	I-protein	8	OBJ	I-protein
O	O	1430	1432	is	be	B-VP	VBZ	O	5	VMOD	O
O	O	1433	1442	concluded	conclude	I-VP	VBN	O	13	VC	O
O	O	1443	1447	from	from	B-PP	IN	O	14	VMOD	O
O	O	1448	1451	the	the	B-NP	DT	O	17	NMOD	O
O	O	1452	1461	inability	inability	I-NP	NN	O	15	PMOD	O
O	O	1462	1464	of	of	B-PP	IN	O	17	NMOD	O
T8	B-Protein	1465	1468	PKC	PKC	B-NP	NN	B-protein	21	NMOD	B-protein
T8	I-Protein	1468	1469	-	-	O	HYPH	O	21	P	O
T8	I-Protein	1469	1473	zeta	zeta	B-NP	SYM	O	24	P	O
O	O	1473	1474	(	(	O	(	O	24	DEP	O
O	O	1474	1477	mut	mut	B-NP	NN	O	24	DEP	O
O	O	1477	1478	)	)	O	)	O	18	PMOD	O
O	O	1479	1481	to	to	B-VP	TO	O	26	VMOD	O
O	O	1482	1491	interfere	interfere	I-VP	VB	O	17	NMOD	O
O	O	1492	1496	with	with	B-PP	IN	O	26	VMOD	O
O	O	1497	1500	the	the	B-NP	DT	O	33	NMOD	O
O	O	1501	1506	basal	basal	I-NP	JJ	O	33	NMOD	O
O	O	1507	1509	or	or	I-NP	CC	O	33	NMOD	O
O	O	1510	1517	phorbol	phorbol	I-NP	NN	O	33	NMOD	O
O	O	1518	1527	myristate	myristate	I-NP	NN	O	33	NMOD	O
O	O	1528	1535	acetate	acetate	I-NP	NN	O	36	NMOD	O
O	O	1535	1536	-	-	B-NP	HYPH	O	36	P	O
O	O	1536	1545	inducible	inducible	I-NP	JJ	O	36	NMOD	O
T9	B-Protein	1546	1550	CREB	CREB	I-NP	NN	B-protein	40	SUB	B-protein
O	O	1550	1551	-	-	B-NP	HYPH	O	36	P	O
O	O	1552	1554	or	or	I-NP	CC	O	39	NMOD	O
T24	B-Entity	1555	1558	AP1	AP1	I-NP	NN	B-protein	36	NMOD	B-protein
O	O	1558	1559	-	-	O	HYPH	O	43	NMOD	O
O	O	1559	1568	dependent	dependent	B-NP	JJ	O	43	NMOD	O
O	O	1569	1584	transcriptional	transcriptional	I-NP	JJ	O	43	NMOD	O
O	O	1585	1593	activity	activity	I-NP	NN	O	27	PMOD	O
O	O	1593	1594	.	.	O	.	O	5	P	O

O	O	1595	1601	Lastly	Lastly	B-ADVP	RB	O	4	VMOD	O
O	O	1601	1602	,	,	O	,	O	4	P	O
O	O	1603	1605	we	we	B-NP	PRP	O	4	SUB	O
O	O	1606	1617	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	1618	1619	a	a	B-NP	DT	O	7	NMOD	O
O	O	1620	1629	selective	selective	I-NP	JJ	O	7	NMOD	O
O	O	1630	1640	inhibition	inhibition	I-NP	NN	O	4	OBJ	O
O	O	1641	1643	of	of	B-PP	IN	O	7	NMOD	O
O	O	1644	1647	p24	p24	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	1648	1658	production	production	I-NP	NN	O	8	PMOD	O
O	O	1659	1661	by	by	B-PP	IN	O	7	NMOD	O
O	O	1662	1665	HIV	HIV	B-NP	NN	O	16	NMOD	O
O	O	1665	1666	-	-	O	HYPH	O	16	P	O
O	O	1666	1674	infected	infect	B-NP	VBN	O	16	NMOD	O
O	O	1675	1680	human	human	I-NP	JJ	B-cell_type	16	NMOD	B-cell_type
O	O	1681	1692	macrophages	macrophage	I-NP	NNS	I-cell_type	11	PMOD	I-cell_type
O	O	1693	1697	when	when	B-ADVP	WRB	O	4	VMOD	O
O	O	1698	1705	treated	treat	B-VP	VBN	O	17	SBAR	O
O	O	1706	1710	with	with	B-PP	IN	O	18	VMOD	O
T25,T26	B-Entity,B-Entity	1711	1713	AO	AO	B-NP	NN	O	19	PMOD	O
T25	I-Entity	1714	1716	to	to	B-PP	TO	O	18	VMOD	O
T25	I-Entity	1717	1720	PKC	PKC	B-NP	NN	B-protein	24	NMOD	B-protein
T25	I-Entity	1720	1721	-	-	B-NP	HYPH	O	24	NMOD	O
T25	I-Entity	1721	1725	zeta	zeta	I-NP	NN	O	21	PMOD	O
T25	I-Entity	1725	1726	.	.	O	.	O	4	P	O

O	O	1727	1737	Altogether	Altogether	B-ADVP	RB	O	5	VMOD	O
O	O	1737	1738	,	,	O	,	O	5	P	O
O	O	1739	1744	these	these	B-NP	DT	O	4	NMOD	O
O	O	1745	1752	results	result	I-NP	NNS	O	5	SUB	O
O	O	1753	1760	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1761	1765	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	1766	1774	atypical	atypical	B-NP	JJ	B-protein	9	NMOD	B-protein
O	O	1775	1778	PKC	PKC	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	1779	1789	isoenzymes	isoenzyme	I-NP	NNS	I-protein	16	SUB	I-protein
O	O	1789	1790	,	,	O	,	O	9	P	O
O	O	1791	1800	including	include	B-PP	VBG	O	9	NMOD	O
O	O	1801	1804	PKC	PKC	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	1804	1805	-	-	O	HYPH	O	14	P	O
O	O	1805	1809	zeta	zeta	B-NP	SYM	O	11	PMOD	O
O	O	1809	1810	,	,	O	,	O	9	P	O
O	O	1811	1822	participate	participate	B-VP	VBP	O	6	SBAR	O
O	O	1823	1825	in	in	B-PP	IN	O	16	VMOD	O
O	O	1826	1829	the	the	B-NP	DT	O	21	NMOD	O
O	O	1830	1836	signal	signal	I-NP	NN	O	21	NMOD	O
O	O	1837	1849	transduction	transduction	I-NP	NN	O	21	NMOD	O
O	O	1850	1858	pathways	pathway	I-NP	NNS	O	17	PMOD	O
O	O	1859	1861	by	by	B-PP	IN	O	16	VMOD	O
O	O	1862	1867	which	which	B-NP	WDT	O	22	PMOD	O
O	O	1868	1871	HIV	HIV	B-NP	NN	O	25	NMOD	O
O	O	1872	1881	infection	infection	I-NP	NN	O	26	SUB	O
O	O	1882	1889	results	result	B-VP	VBZ	O	22	SBAR	O
O	O	1890	1892	in	in	B-PP	IN	O	26	VMOD	O
O	O	1893	1896	the	the	B-NP	DT	O	29	NMOD	O
O	O	1897	1907	activation	activation	I-NP	NN	O	27	PMOD	O
O	O	1908	1910	of	of	B-PP	IN	O	29	NMOD	O
T27	B-Entity	1911	1913	NF	NF	B-NP	NN	B-protein	34	NMOD	B-protein
T27	I-Entity	1913	1914	-	-	B-NP	HYPH	I-protein	34	NMOD	I-protein
T27	I-Entity	1914	1919	kappa	kappa	I-NP	NN	I-protein	34	NMOD	I-protein
T27	I-Entity	1920	1921	B	B	I-NP	NN	I-protein	30	PMOD	I-protein
O	O	1922	1924	in	in	B-PP	IN	O	29	NMOD	O
O	O	1925	1930	human	human	B-NP	JJ	B-cell_type	38	NMOD	B-cell_type
O	O	1931	1940	monocytic	monocytic	I-NP	JJ	I-cell_type	38	NMOD	I-cell_type
O	O	1941	1946	cells	cell	I-NP	NNS	I-cell_type	40	NMOD	I-cell_type
O	O	1947	1950	and	and	O	CC	O	40	NMOD	O
O	O	1951	1962	macrophages	macrophage	B-NP	NNS	B-cell_type	35	PMOD	B-cell_type
O	O	1962	1963	.	.	O	.	O	5	P	O
